FDA Minds DTC “Reminder Ad” Increase, Seeks Better “Brief Summaries”
This article was originally published in The Tan Sheet
Executive Summary
FDA is concerned that industry may be using "reminder ads" more frequently as a way to avoid including risk information in direct-to-consumer marketing